AMGN

Amgen Inc. (NASDAQ:AMGN) is one of the world's largest independent biotechnology companies, founded in 1980 and headquartered in Thousand Oaks, California. The company went public in 1983 and has grown to become a leading developer and manufacturer of human therapeutics focused on serious illnesses. Amgen operates globally, serving healthcare providers including physicians, dialysis centers, hospitals, and pharmacies through pharmaceutical wholesale distributors and direct channels. The company has built its reputation on innovative biotechnology medicines, particularly in areas where few treatment options previously existed.